Tumor-on-Chip Platform Development & Validation

About Solid IO

Solid IO is a Helsinki-based deep tech startup pioneering a tumor-on-chip platform designed to transform precision oncology and immunotherapy. By creating patient-specific models that replicate the tumor microenvironment, the platform aims to predict treatment responses in real-time, enabling more informed clinical decisions and reducing trial-and-error for patients. The company is currently in the research and development phase, collaborating with pharmaceutical and clinical partners to validate its technology and advance towards clinical application. Solid IO represents a convergence of bioengineering, AI, and translational cancer biology with the goal of making personalized cancer medicine a standard of care.

Therapeutic Areas